SynthesisFrontiers in microbiology2026
Bibliometric analysis of research on spinal cord injury and the gut microbiota.
Synthesis in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To map the research landscape, knowledge base, hotspots, and emerging trends in studies of spinal cord injury (SCI) and the gut microbiota using bibliometric methods. Methods: English-language original articles and reviews on SCI and the gut microbiota published from January 1, 2000, to March 25, 2026 were retrieved from the Web of Science Core Collection (WoSCC) and Scopus. VOSviewer, CiteSpace, and Bibliometrix were used to analyze publication trends, collaboration networks, co-cited references, journals, authors, and keyword evolution. Results: A total of 4,857 publications were included, comprising 3,134 original articles and 1,723 reviews. Annual output increased markedly after 2019. China and the United States were the leading contributors, and Capital Medical University and Wenzhou Medical University were among the most productive institutions. Core journals included Spinal Cord, The Journal of Spinal Cord Medicine, Experimental Neurology, and Journal of Neurotrauma. Co-citation and keyword analyses indicated a shift in research attention from clinical phenotypes and complication management toward the gut-spinal cord axis, microbiota-derived metabolites, neuroinflammation, immune regulation, probiotics, short-chain fatty acids, and ferroptosis. Conclusion: Research on SCI and the gut microbiota has become a rapidly growing interdisciplinary field. Future studies should strengthen causal inference, mechanistic validation, multi-omics integration, and high-quality clinical translation of gut microbiota-targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.